English
Korean
GBIOLOGICS

Biotechnology company

GBIOLOGICS
홈으로
PLATFORM
PLATFORM
PLATFORM
sGal-9 is a new “stable” recombinant protein with enhanced stability and solubility, which can be developed for various indications.
sGalectin-9

Platform

  • Rheumatoid Arthritis

    Suppressing FLS proliferation

  • Cancer

    Inducing cell apoptosis

  • Systemic Lupus
    Erythematosus

    Inhibiting TLR mediated autoimmunity

  • Anti-viral